Stock FDC FDC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials FDC Limited

Equities

FDC

INE258B01022

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
455.8 INR -0.24% Intraday chart for FDC Limited +1.59% +15.09%
Feb. 07 FDC Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 FDC Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 44,769 29,213 33,502 48,229 43,367 42,564
Enterprise Value (EV) 1 40,550 24,961 28,332 42,822 38,304 38,036
P/E ratio 25.8 x 17.2 x 14.1 x 16.1 x 20 x 22 x
Yield - - 0.41% - - -
Capitalization / Revenue 4.16 x 2.68 x 2.49 x 3.62 x 2.84 x 2.39 x
EV / Revenue 3.77 x 2.29 x 2.11 x 3.21 x 2.51 x 2.13 x
EV / EBITDA 17.5 x 10.9 x 9.5 x 13.1 x 15.6 x 15.7 x
EV / FCF 40.1 x 37.6 x 18.6 x 32.7 x 159 x 349 x
FCF Yield 2.49% 2.66% 5.39% 3.05% 0.63% 0.29%
Price to Book 3.44 x 2.02 x 2.17 x 2.78 x 2.22 x 2.15 x
Nbr of stocks (in thousands) 177,833 174,403 170,973 168,810 168,810 165,910
Reference price 2 251.8 167.5 196.0 285.7 256.9 256.6
Announcement Date 5/25/18 8/31/19 9/8/20 9/6/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 10,751 10,907 13,442 13,332 15,279 17,838
EBITDA 1 2,313 2,293 2,981 3,267 2,461 2,424
EBIT 1 1,979 1,978 2,673 2,962 2,164 2,120
Operating Margin 18.41% 18.13% 19.88% 22.22% 14.16% 11.89%
Earnings before Tax (EBT) 1 2,406 2,366 3,200 3,877 2,894 2,578
Net income 1 1,735 1,698 2,399 3,013 2,164 1,940
Net margin 16.14% 15.57% 17.85% 22.6% 14.16% 10.88%
EPS 2 9.758 9.735 13.94 17.73 12.82 11.67
Free Cash Flow 1 1,011 664.1 1,526 1,308 241 109.1
FCF margin 9.4% 6.09% 11.35% 9.81% 1.58% 0.61%
FCF Conversion (EBITDA) 43.68% 28.96% 51.18% 40.04% 9.8% 4.5%
FCF Conversion (Net income) 58.24% 39.11% 63.61% 43.41% 11.14% 5.62%
Dividend per Share - - 0.8000 - - -
Announcement Date 5/25/18 8/31/19 9/8/20 9/6/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q3
Net sales 1 4,475 3,976 3,418 4,947 4,450 4,093
EBITDA 1,155 712.1 478.1 780 673.2 -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/12/21 11/11/21 2/9/22 8/4/22 11/14/22 2/9/23
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 4,220 4,251 5,170 5,407 5,063 4,529
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 1,011 664 1,526 1,308 241 109
ROE (net income / shareholders' equity) 13.6% 12.5% 16% 18.4% 11.7% 9.84%
ROA (Net income/ Total Assets) 8.32% 7.86% 9.68% 9.82% 6.4% 5.75%
Assets 1 20,846 21,601 24,792 30,673 33,815 33,773
Book Value Per Share 2 73.20 82.90 90.50 103.0 116.0 119.0
Cash Flow per Share 2 1.610 1.140 1.750 1.800 2.230 1.440
Capex 1 370 427 312 625 1,325 1,131
Capex / Sales 3.44% 3.92% 2.32% 4.69% 8.67% 6.34%
Announcement Date 5/25/18 8/31/19 9/8/20 9/6/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FDC LIMITED Stock FDC Limited
+15.09% 890M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. FDC Stock
  4. Financials FDC Limited